Narrow Band Imaging Versus White Light for Colonoscopy Serrate Lesions Detection
NCT ID: NCT02876133
Last Updated: 2018-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
987 participants
INTERVENTIONAL
2016-11-30
2019-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our aim is to evaluate narrow band imaging (NBI) during colonoscopy and serum miRNAs as novel tools for the early detection of colonic sessile serrated lesions (SSL). The investigators will perform a multicenter-randomized-controlled-trial to study the role of NBI in SSL detection.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Narrow-Band Imaging Versus Standard White Light for the Detection of Serrated Lesions in the Proximal Colon
NCT01572428
Diagnosis of Colonic Adenomas by Bright Narrow Band Imaging (B-NBI)
NCT01422577
Comparison Between White Light Endoscopy and Bright Narrow Band Imaging in Diagnosis Colonic Adenomas.
NCT01737567
Study of Narrow Band Imaging in the Characterization of Serrated Lesions
NCT02406547
Study of Narrow Band Imaging in the Characterization of Residual Neoplasia After Endoscopic Piecemeal Mucosal Resection
NCT02448693
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Narrow band imaging withdrawal
colonoscope withdrawal and mucosal inspection performed under narrow band imaging
narrow band imaging withdrawal
colonoscope withdrawal and mucosal inspection performed under narrow band imaging
white light withdrawal
colonoscope withdrawal and mucosal inspection performed under white light imaging
white light withdrawal
colonoscope withdrawal and mucosal inspection performed under white light imaging
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
narrow band imaging withdrawal
colonoscope withdrawal and mucosal inspection performed under narrow band imaging
white light withdrawal
colonoscope withdrawal and mucosal inspection performed under white light imaging
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* primary sclerosing cholangitis
* inflammatory bowel disease
* personal colorectal cancer history
40 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Beatriz Ângelo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexandre Ferreira
Gastroenterologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandre O Ferreira, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Beatriz Ângelo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Beatriz Ângelo
Loures, , Portugal
Centro Hospitalar do Porto
Porto, , Portugal
Instituto Português de Oncologia do Porto
Porto, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, Goldblum JR, Guillem JG, Kahi CJ, Kalady MF, O'Brien MJ, Odze RD, Ogino S, Parry S, Snover DC, Torlakovic EE, Wise PE, Young J, Church J. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012 Sep;107(9):1315-29; quiz 1314, 1330. doi: 10.1038/ajg.2012.161. Epub 2012 Jun 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
176
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.